Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Xencor, Inc.
Hoffmann-La Roche
Emory University
Children's Oncology Group
M.D. Anderson Cancer Center
Massachusetts General Hospital
St. Jude Children's Research Hospital
Loma Linda University
Memorial Sloan Kettering Cancer Center
Indiana University
UNC Lineberger Comprehensive Cancer Center